We work to translate scientific concepts into commercial products for patients with unmet needs and the general population
In one Phase 2 trial of people with obesity, called VISTA, those on the highest dose of the drug, called elecoglipron, lost 11.2% of their weight after 36 weeks, when looking at all patients regardless of discontinuations, according to data presented Monday at the annual meeting of the American Diabetes Association and published in the Lancet
FAQs What does GLP-1 hypertension mean
S., Amaro, A., & Wadden, T
Nearly half (47%) named it the single biggest thing keeping them from starting, well ahead of side-effect concerns (27%) or uncertainty about whether it was right for them (18%)
Voor energie en uithoudingsvermogen: nuttig in combinatie met pre-workout om sportprestaties te verbeteren